Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9862952
SERIAL NO

15089437

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to novel targets for angiogenic disorders. Novel oligonucleotides are also provided. Methods of using the novel oligonucleotides for the treatment of angiogenic disorders (e.g., preeclampsia) are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MASSACHUSETTS225 FRANKLIN STREET 12TH FLOOR BOSTON MA 02110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Karumanchi, Ananth Chestnut Hill, US 11 140
Khvorova, Anastasia Westborough, US 393 10160
Moore, Melissa Chestnut Hill, US 25 736
Turanov, Anton A Boston, US 4 117

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 9, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 9, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00